ArticlePloS one2014

Olmesartan potentiates the anti-angiogenic effect of sorafenib in mice bearing Ehrlich's ascites carcinoma: role of angiotensin (1-7).

Mohammad M Abd-Alhaseeb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.